A 3D rendering of a neuron
Independent FDA Advisory Panel Recommends Approving ALS Drug
The group’s 7-2 ruling in favor of the therapeutic represents a shift from previous deliberations, in which data on its effectiveness was deemed insufficient.
Independent FDA Advisory Panel Recommends Approving ALS Drug
Independent FDA Advisory Panel Recommends Approving ALS Drug

The group’s 7-2 ruling in favor of the therapeutic represents a shift from previous deliberations, in which data on its effectiveness was deemed insufficient.

The group’s 7-2 ruling in favor of the therapeutic represents a shift from previous deliberations, in which data on its effectiveness was deemed insufficient.

clinical research
A red sign that reads “Clinical Center, Building 10” outside of a brick building
NIH Fails to Enforce Rules for Reporting Clinical Trial Results
Amanda Heidt | Aug 18, 2022
A review by the US Office of Inspector General found that only about half of the scientists running clinical trials funded by the NIH in 2019 and 2020 appropriately recorded their findings in a federal database, as is legally required.
Tiny diverse scientists are studying the covid-19 virus under a giant microscope. Vaccine development concept
Opinion: Many Clinical Trials Fail to Navigate the Literature
Jacky Sheng, Jonathan Kimmelman, and Deborah Zarin | Jul 5, 2022
Too often, studies that aim to develop new treatments for patients fail to adequately cite and build upon research that preceded them.
Modeling the Human Lung with Organoids
The Scientist Creative Services Team in collaboration with MilliporeSigma
A new specialized cell culture media system generates induced pluripotent stem cell-derived lung organoids that more closely resemble the diversity of cell types found in the human lung.
Round white pills on a wooden surface
No Reduction in COVID-19 Hospitalizations, Deaths with Ivermectin
Catherine Offord | Jun 13, 2022
The ACTIV-6 trial reports that people who took the drug for three days may have spent slightly less time feeling unwell with SARS-CoV-2, but fails to find differences in disease progression between the treatment and placebo groups.
Vaccine illustration 
Infographic: Inducing Active Immunity Against Opioid Overdose
Tori Rodriguez | Jun 13, 2022
How scientists aim to induce an immune response against addictive drugs
Beauty Is More Than Skin Deep: 3D Imaging from Micro to Macro
The Scientist Creative Services Team
Lai Guan Ng will discuss how whole-skin imaging advances skin immunity research.
Illustration of a syringe with a person falling out of a bottle of pills
Opioid Vaccines as a Tool to Stem Overdose Deaths
Tori Rodriguez | Jun 13, 2022
Researchers are turning to the immune system for help in treating addiction and preventing overdose.
Spraying spray bottle
Nasal Vaccines Are Commercially High Risk, Perhaps High Reward
Jef Akst | Jun 13, 2022
Dozens of intranasally delivered vaccines targeting SARS-CoV-2 are in development. Could they pave the way for widespread nasal vaccination in the future?
Liver Dysfunction: Causes and Mechanisms
The Scientist Creative Services Team
Learn about the underlying causes and mechanisms behind liver pathophysiology.
Open orange pill bottle with rounded white pills
What’s the Evidence for Fluvoxamine in COVID-19? 
Catherine Offord | May 20, 2022
The US FDA’s decision not to grant an emergency use authorization for the antidepressant as a COVID-19 treatment highlights a lack of consensus among researchers about how to interpret clinical data on the drug.
Bacteria on the skin
Biotech Tries Manipulating the Skin Microbiome
Bianca Nogrady | Apr 18, 2022
Researchers are revealing the complexity of the microbial community living on the body—and paving the way for new bacteria-targeting treatments for acne and other dermatological conditions.
CRISPR Technologies for the New Era of Cell and Gene Therapy
The Scientist Creative Services Team
Experts will discuss how they use new CRISPR technologies to advance their cell and gene therapy research.
illustration of a brain divided into 4 puzzle pieces
Why Autism Therapies Have an Evidence Problem
Rachel Zamzow | Apr 14, 2022
Some experts argue that better trials are needed before putting interventions into practice.
Older woman with hat and pink blouse smiling at camera.
Anne Beaumanoir, Activist and Clinical Neurologist, Dies at 98
Natalia Mesa | Mar 29, 2022
Beaumanoir helped Jews evade Nazis during World War II and aided resistance fighters during the Algerian War of Independence. She also contributed to the field of epileptology.
Thwarting a Pandemic: COVID-19 Vaccine Strategies
The Scientist Creative Services Team
Download this poster to learn about promising vaccine candidates for COVID-19!
Special Report
lone birch tree growing sideways in a field
Amid the Terror of War, Efforts to Keep Science Alive in Ukraine
Katarina Zimmer | Mar 28, 2022
Ukrainian scientists and universities face extraordinary challenges as the Russian invasion continues.
Illustration of scientists collaborating
How to Bring the Public into the Scientific Process
Amanda Heidt | Mar 14, 2022
A new wave of research is recruiting patients and other members of the public to serve as equal partners, bringing fresh perspectives to research on diseases and other conditions.
Biobanking and the Future of Precision Medicine
The Scientist Creative Services Team
Erik Steinfelder and Bogi Eliasen will examine the importance of biobanking in precision medicine, from early-stage research to diagnostics and treatments.
Doctor holding stethoscope in front of European Union flag
New EU Protocol Aims to Improve Clinical Trial Transparency
Sophie Fessl | Feb 16, 2022
A new regulation and registry covering investigational medicinal products mandates reporting and supports multinational trials.